We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
A thought leadership media platform working with trusted experts to bring innovative advancements to organisations through journalism. The Future Shapers aims to re-imagine how information is delivered globally and the ways it can help small to large communities innovate further, avoiding the use of advertisers and paywalls.
days to go: Expired investment: £41,610
TradeZapp is a collaboration of experienced tradespeople and leading technology professionals. The company has a close understanding of its target market and the challenges associated with it like connecting consumers with professional trade services for latest work opportunities. TradeZapp provides the market with on-demand home services in the UK as well as all over the world. The company's V1 pilot app is available for download on both Android and iOS. TradeZapp also has a fully developed: V2 working prototype that is ready for cross-platform development. It might have the opportunity to raise series A funding and grow into other key international markets.
days to go: Expired investment: Withheld
Tregiv is a web and application-based platform which can be used for giving of monetary gifts for all festivals. As the money gifted, the tree grows and, it also holds personal messages. The company has future strategic partnerships planned; TreGiv cash for savings online. The money is kept secure within the MangoPay payment platform. A part of the investment will be used for the fulfilment of the front end web platform, application integration & payment interface, and the remaining will go for working capital and marketing costs.
days to go: Expired investment: £25,080
Simply rounding up the value of online purchases to the nearest pound and enabling users to save money into a digital wallet. Wishwallet aims to solve the problem of online shopping trolley abandonment, whereby consumers tend to leave products in their online baskets, but not continue to the checkout stage. The company aims to reduce this issue, whilst at the same time allowing customers to afford products and services they not have been able to before. Wishwallet's revenue stream is comprised of service fees to retailers, advertisements, recurring subscriptions and data. The company aims to launch their service with access to more than 1,500 retailers. They have already completed Phase 1 of their app development cycle and following this investment round, they aim to complete their product to be ready to launch in early 2019. Any additional contributions will be used for marketing campaigns, key hires and future app upgrades.
days to go: Expired investment: £122,140
Yanda is the place where the customer can create his or own trading bot from scratch without any deposit or coding. Since 2018, the company has opened more than 9,000 accounts and, its traders are able to execute 16,000 trading bots with a success rate of more than 97 %. Yanda traders have created more than 17,000 trading strategies. Its software allows cryptocurrency traders to automate their trading strategy. Yanda makes trading cryptocurrencies simpler and less time-consuming. It has over 1000 followers on Twitter and every week it publishes market updates on its blog. Yanda believes that automated trading for the cryptocurrency is the future. Its mission is to reach out to more than 10 million cryptocurrency holders worldwide.
days to go: Expired investment: £24,380
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph